Revenues from continuing operations for the nine months ended September 30, 2010 were $61.9 million, a 23% increase from $50.1 million for the same nine month period in 2009. Net loss for the nine months ended September 30, 2010 was $208 thousand, or $(0.03) per share compared with a net loss of $9.6 million, or $(1.15) per share, for the same period in 2009. These results include a net gain of $1.5 million or $0.18 per share and a net loss of $1.6 million, or $(0.20) per share, for the nine month period ended September 30, 2010, and 2009, respectively, from the Company’s Medical Products Business unit which has been classified as a discontinued operation.
Solar Project Development & Finance Tour India 2015
05 Oct - 09 Oct
New Delhi - Hyderabad, India
Solar PV Trade Mission Central America & Colombia 2015
16 Nov - 20 Nov
Panama City, Panama & Bogota, Colombia